With the aid of patients, care partners, and multiple academic, private, and public communities, the Kidney Health Initiative’s newly developed technology roadmap is catalyzing innovative approaches to kidney replacement therapy (KRT). The roadmap provides guidance for innovators and entrepreneurs who are working to redesign dialysis and provide better care for those with kidney disease.
Fluid management is an area ripe for innovation that has a significant impact on the quality of life of people with kidney failure. The Kidney Health Initiative (KHI) recently released a supplement to its Technology Roadmap for Innovative Approaches to Renal Replacement Therapy entitled Fostering Innovation in Fluid Management. This report provides guidance to spur innovation in fluid management devices and techniques. Similar to the original roadmap, this new report is built around patient preferences and provides details on design requirements, functional areas, and development timelines.
Announced July 25, Dr. Reshma Kewalramani will be promoted to president and CEO of Vertex Pharmaceuticals. She is currently the chief medical officer for the company and was previously a practicing nephrologist who earned her medical doctorate at Boston University and trained at Bigham & Women’s Hospital.
Dr. Kewalramani will be the first woman to run a large biotechnology firm. Vortex’s share price “rose 360% and its sales doubled to $3 billion annually” under the previous CEO, largely due the company’s pharmaceuticals used to treat cystic fibrosis.
On July 11, the U.S. Department of Health and Human Services, American Society of Nephrology, and the National Kidney Foundation announced the new Patient Innovator Challenge.
The new prize competition seeks to identify ideas and solutions patients and care partners have developed to improve their daily life with kidney disease. The KidneyX Patient Innovator Challenge, funded by the National Kidney Foundation (NKF) invited individuals, communities, businesses, institutions, and not-for-profit organizations, among others, to submit ideas on how to improve therapeutic options and quality for life for people living with kidney disease.
Session on Collaborating for Innovation to Support KidneyX
Eric Hargan, Deputy Secretary at the US Department of Health and Human Services (HHS) began the second day by sharing HHS’s priorities for kidney care. First, to increase efforts at preventing, detecting, and slowing the progression of kidney diseases. Second, to provide more treatment options to people with kidney failure. Third, to increase the number of transplantable organs and develop wearable and artificial kidneys.
The Kidney Health Initiative (KHI) hosted its Seventh Annual Stakeholders Meeting May 29-30, in Washington DC. The annual meeting revolved around the theme of “Collaborating for Innovation to Improve Patient Care and Outcomes”. Planning Committee Co-Chairs Paul T. Conway and Mahesh Krishnan, MD, FASN, developed a program that attracted nearly 200 registrants. The “think-tank” style meeting included onstage Q&A with government representatives, presentations from leaders in the kidney community, and member showcases highlighting innovations around the KHI membership.
On Wednesday, May 8, the House Appropriations Committee voted to send the House Labor, Health and Human Services, and Education (LHHS) appropriations bill to the House floor for consideration. The bill and accompanying committee report provides a total of $189.9 billion in funding, a nearly $12 billion increase over FY 19 enacted levels, and includes a number of priorities of the American Society of Nephrology (ASN).
The KidneyX Summit continued today, April 30, 2019, with congressional perspectives; the role of NIH, FDA, and payors; and the nephrology investment landscape all addressed during the second day of the event.